The rationale to examine an Akt inhibitor as a potential candidate to treat leishmaniasis came from our recent studies that Leishmania activates Akt signaling in infected cells [5,7,8] to promote the persistence of the infection. The gene discussed is AKT1; the disease is leishmaniasis.